Skip to content

Drug interactions

Daunorubicin + Dengue vaccine

Severity: Major

Daunorubicin and Dengue vaccine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dengue vaccine (Dengvaxia) is a live attenuated vaccine. In patients receiving myelosuppressive chemotherapy, immune response may be reduced and the vaccine virus could cause disease.

What this interaction means in plain words

Daunorubicin and Dengue vaccine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Chemotherapy-induced immunosuppression impairs vaccine response and permits live vaccine virus replication.

What to do

Avoid live vaccines during chemotherapy and until immune recovery, as advised by the vaccine labeling and oncology guidance.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daunorubicin and Dengue vaccine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Daunorubicin with Dengue vaccine?

MediHelp rates the interaction as major. Daunorubicin and Dengue vaccine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dengue vaccine (Dengvaxia) is a live attenuated vaccine. In patients receiving myelosuppressive chemotherapy, immune response may be reduced and the vaccine virus could cause disease.

How serious is the interaction between Daunorubicin and Dengue vaccine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid live vaccines during chemotherapy and until immune recovery, as advised by the vaccine labeling and oncology guidance.

What other medicines interact with Daunorubicin?

MediHelp also lists interactions of Daunorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclosporine. The full list is on the Daunorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in